Near-infrared spectroscopy predicts cardiovascular outcome in patients with coronary artery disease
Background Near-infrared spectroscopy (NIRS) is capable of identifying lipid core-containing plaques, which can subsequently be quantified as a lipid core burden index (LCBI). Currently, no data are available on the long-term prognostic value of NIRS in patients with coronary artery disease (CAD). Objectives This study sought to determine the long-term prognostic value of intracoronary NIRS as assessed in a nonculprit vessel in patients with CAD. Methods In this prospective, observational study, NIRS imaging was performed in a nonculprit coronary artery in 203 patients referred for angiography due to stable angina pectoris (SAP) or acute coronary syndrome (ACS). The primary endpoint was the composite of all-cause mortality, nonfatal ACS, stroke, and unplanned coronary revascularization. RESULTS The 1-year cumulative incidence of the primary endpoint was 10.4%. Cumulative 1-year rates in patients with an LCBI equal to and above the median (43.0) versus those with LCBI values below the median were 16.7% versus 4.0% (adjusted hazard ratio: 4.04; 95% confidence interval: 1.33 to 12.29; p = 0.01). The relation between LCBI and the primary endpoint was similar in SAP and ACS patients (p value for heterogeneity = 0.14). Similar differences between high and low LCBI were observed in pre-specified secondary endpoints. CONCLUSION CAD patients with an LCBI equal to or above the median of 43.0, as assessed by NIRS in a nonculprit coronary artery, had a 4-fold risk of adverse cardiovascular events during 1-year follow-up. This observation warrants confirmation by larger studies with extended follow-up.
|Keywords||Atherosclerosis, Intracoronary imaging, Risk stratification|
|Persistent URL||dx.doi.org/10.1016/j.jacc.2014.07.998, hdl.handle.net/1765/90421|
|Journal||Journal of the American College of Cardiology|
Oemrawsingh, R.M, Cheng, J.M, Garcia-Garcia, H.M, van Geuns, R.J.M, de Boer, S.P.M, Simsek, C, … Boersma, H. (2014). Near-infrared spectroscopy predicts cardiovascular outcome in patients with coronary artery disease. Journal of the American College of Cardiology, 64(23), 2510–2518. doi:10.1016/j.jacc.2014.07.998